HPV DNA testing as an adjunct in the management of patients with low grade cytological lesions in Finland

References

• Finnish Cancer Registry – Institute for Statistical and Epidemiological Cancer Research: Cancer in Finland, 2002 and 2003. Cancer Statistics of the National Research and Development Centre for Welfare and Health. Cancer Society of Finland Publication No. 66. Helsinki 2005. http://www.cancerregistry.fi/eng/statistics.
   Google Scholar
• Kinney WK, Manos MM, Hurley LB, Ransley JE. Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diseases. Obstet Gynecol. 1998; 91: 973–6
   PubMed Web of Science ®Google Scholar
• Cox JT, Schiffman M, Solomon D; ASCUS-LSIL Triage Study (ALTS) Group. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol. 2003;188:1406–12.
   PubMed Web of Science ®Google Scholar
• Wright TC, Cox JT, Massad S, Twiggs LB, Wilkinson EJ; for the 2001 ASCCP-Sponsored Consensus Conference. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287:2120–9.
   PubMed Web of Science ®Google Scholar
• Schiffman M, Solomon D. Findings to date from the ASCUS-LSIL Triage Study (ALTS). Arch Pathol Lab Med. 2003; 127: 946–9
   PubMed Web of Science ®Google Scholar
• Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. for the Forum Group Members and the Bethesda 2001 Workshop. The 2001 Bethesda System. Terminology for reporting results of cervical cytology. JAMA. 2002; 287: 2114–9
   PubMed Web of Science ®Google Scholar
• Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, et al. Overexpression of p16INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001; 92: 2276–84
   Web of Science ®Google Scholar
• de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol. 1995; 76: 1057–62
   PubMed Web of Science ®Google Scholar
• van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ. GP5 + /6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol. 2002; 40: 779–87
   PubMed Web of Science ®Google Scholar
• Jastania R, Geddiw WR, Chapman W, Boerner S. Characteristics of apparently false-negative Digene Hybrid Capture 2 high-risk HPV DNA testing. Am J Clin Pathol. 2006; 125: 1–6
   Web of Science ®Google Scholar
• Maksem JA, Bedrossian CW, Kurtycz D, Sewall S, Shalkam J, Dhanwada V, et al. Resolving ASCUS without recourse to HPV testing: manual reprocessing of residual automated liquid-based cytology (ALBC) material using manual liquid-based cytology (MLBC). Diagn Cytopathol. 2005; 33: 434–40
   PubMed Web of Science ®Google Scholar
• Kalliala I, Anttila A, Pukkala E, Nieminen P. Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study. BMJ. 2005; 331: 1183–5
   PubMed Web of Science ®Google Scholar
• Santos AL, Derchain SF, Sarian LO, Martins MR, Morais SS, Syrjanen KJ. Performance of pap smear and human papilloma virus testing in the follow-up of women with cervical intraepithelial neoplasia grade 1 managed conservatively. Acta Obstet Gyn Scand. 2006; 85: 444–50
   PubMed Web of Science ®Google Scholar
• Kulasingam SL, Kim JJ, Lawrence WF, Mandelblatt JS, Myers ER, Schiffman M, et al. Cost-effectiveness analyses based on the atypical squamous cells of undetermined significance/low grade intraepithelial lesion triage study (ALTS). J Natl Cancer Inst. 2006; 98: 92–100
   PubMed Web of Science ®Google Scholar
• Legood R, Gray A, Wolstenholme J, Moss S. Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies. BMJ. 2006; 332: 79–85
   PubMed Web of Science ®Google Scholar
• Sadler L, Saftlas A, Wang W, Exeter M, Whittaker J, McCowan L. Treatment for cervical intraepithelial neoplasia and risk preterm delivery. JAMA. 2004; 29: 2100–6
   Web of Science ®Google Scholar
• Samson SL, Bentley JR, Fahey TJ, McKay DJ, Gill GH. The effect of loop electrosurgical excision procedure on future pregnancy. Obstet Gynecol. 2005; 105: 325–32
   PubMed Web of Science ®Google Scholar
• Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet. 2006; 367: 489–98
   PubMed Web of Science ®Google Scholar
• Miranda Pereira SM, Castelo A, Makabe S, Utagawa ML, Di Loreto C, Sakamoto Maeda MY, et al. Screening for cervical cancer high-risk populations: DNA pap test or Hybrid Capture II test alone?. Int J Gynecol Pathol. 2006; 25: 38–41
   PubMed Web of Science ®Google Scholar